(Australia-NewsWire.Com, May 25, 2018 ) Stem cells are kind of a research tool, as their in vitro study would permit scientists to grasp in depth concerning the role of varied organs and the development of specific illnesses; stem cells can also probably permit drug developers to check emerging therapies on diseased cells. Stem cells therapy has shown substantial potential to treat cancer with success. Cancer stem cells that have been tested on animals have shown satisfactory results.
The Asia-Pacific Stem Cell Assay Market was worth USD 86.61 Million in 2016 and is estimated to be growing at a CAGR of 24.2%, to reach USD 255.9 Million by 2021. Development in infrastructure for stem cell banking and processing have been fueling the expansion of the North America stem cell market.
Drivers and Restraints:
Factors like the growing awareness involving the therapeutic potential of stem cells in disease management and development of advanced genome-based cell analysis techniques act as the most significant factors behind the expansion of the market. The increasing public-private investments for stem cell analysis and identification of modern stem cell lines are also the important factors fueling the market growth.
Since cellular therapies are regarded as the next major step in transforming healthcare, corporations are increasing their cellular therapy portfolio to incorporate a variety of ailments like Parkinson's disease and Alzheimer's disease. Breakthrough innovations brought about in this field are the limitless supply of induced pluripotent stem cells (iPSCs) and efforts for regeneration of dying or unhealthy cells and tissues.
Geographically, Asia-pacific stem cell assay market is segmented into China, India, Japan, Australia and South Korea. Asia-Pacific is expected to be the fastest growing market for stem cell assays with a CAGR of 24.2%. It is due to the increasing adoption of stem cell based therapy and research in this region.
The leading corporations in the present regional market include Athersys, StemCells Inc., Cryo Cell International, Geron Corporation, Mesoblast Ltd., Aastrom Biosciences Inc., Celgene Corporation, Invitrogen and Cytori Therapeutics Inc.
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.